DNA Virus Infections: Clinical Trials

5,370 trials for DNA Virus Infections, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2993 completed, 789 unknown, 512 recruiting, 390 terminated. 1381 Phase 2, 1157 Phase 1, 780 Phase 3, 766 Not applicable, 521 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 21381Completed 746, Terminated 161, Recruiting 141, Unknown 119, Active not recruiting 86, Withdrawn 69, Not yet recruiting 53, Enrolling by invitation 3, Suspended 3
Phase 11157Completed 664, Terminated 137, Recruiting 121, Unknown 89, Active not recruiting 57, Withdrawn 42, Not yet recruiting 36, Enrolling by invitation 7, Suspended 4
Phase 3780Completed 544, Unknown 75, Terminated 47, Recruiting 42, Active not recruiting 40, Not yet recruiting 18, Withdrawn 13, Suspended 1
Not applicable766Completed 398, Unknown 145, Recruiting 88, Not yet recruiting 39, Terminated 38, Active not recruiting 28, Withdrawn 19, Enrolling by invitation 10, Suspended 1
Phase 4521Completed 277, Unknown 140, Recruiting 28, Terminated 21, Active not recruiting 19, Not yet recruiting 16, Withdrawn 13, Enrolling by invitation 7
Early Phase 164Unknown 16, Recruiting 13, Completed 12, Not yet recruiting 10, Withdrawn 5, Active not recruiting 4, Terminated 4

Follow DNA Virus Infections: new trials by email Literature Review of DNA Virus Infections trials Research Report on DNA Virus Infections

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Efficacy and Safety of SR-T100 Gel in Common Warts (CW) Patients
Vehicle gel, SR-T100 gel with 1.0% of SM, SR-T100 gel with 2.3% of SM - Common Wart
Phase 2SuspendedG&E Herbal Biotechnology Co., LTD1022030-09-012023-09-14
Assessment of Myocarditis After Replication-Deficient Smallpox Immunization
JYNNEOS - Myopericarditis, Small Pox
Not yet recruitingWomack Army Medical Center23502029-03-012023-12-14
Maximizing HPV Vaccination: Real-time Reminders, Guidance, and Recommendations - Part 4: Feasibility Trial
Protect Me 4 Application + External Quality Improvement Support, Protect Me 4 Application Alone - Human Papillomavirus (HPV) Vaccines
Not applicableNot yet recruitingUniversity of Florida12962027-09-152026-09-14
Papilozumib Vaginal Gel for Exocervical Mucosal Restoration in Women With Human Papillomavirus (HPV)
Papilozumib vaginal gel, Papilozumib oral supplement - Human Papillomavirus Infection, Human Papillomavirus Infections
Not applicableNot yet recruitingHifas da Terra S.L.812027-07-012026-10-05
Incidence of HPV Infection and HPV-Associated Disease in Screening Indian Men Who Have Sex With HIV-Positive Men
Cytology Specimen Collection Procedure, High Resolution Anoscopy with Biopsy, Laboratory Biomarker Analysis - HIV Infection, Human Papillomavirus Infection
WithdrawnAIDS Malignancy Consortium2027-04-302025-06-06
Genetically Engineered Cells (BAFFR-CAR T Cells) for the Treatment of Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia and B-cell Lymphoblastic Lymphoma
Autologous BAFFR-targeting CAR T Cells, Biospecimen Collection, Bone Marrow Aspiration - Recurrent B Acute Lymphoblastic Leukemia, Recurrent B Lymphoblastic Lymphoma
Phase 1RecruitingCity of Hope Medical Center162027-04-172026-11-13
Phase I Safety Clinical Trial of Anti-CD19 CAR-T Therapy COL01 for the Treatment of Adults With Relapsed or Refractory B-cell Lymphoid Neoplasms: First-in-human Administration, COLIBRI.
CAR-T anti-CD19 COL01 - Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia, Lymphoid Malignancies
Phase 1Not yet recruitingGUSTAVO SALGUERO122027-04-012026-10-20
Asciminib and Inotuzumab Ozogamicin for Relapsed or Refractory Philadelphia Chromosome-positive B-cell Acute Lymphoblastic Leukemia (R/R Ph+ B-ALL)
Asciminib, Inotuzumab ozogamicin - B-cell Acute Lymphoblastic Leukemia (B-ALL)
Phase 1RecruitingSunil G. Iyer452027-03-312026-11-13
Efficacy and Safety of Oral Ivermectin for Genital Warts
Ivermectin - Genital Warts
Not applicableNot yet recruitingUniversity of Health Sciences Lahore902027-02-202026-11-03
Metabolically Fit CD19 CAR T Cells With CD34 Selection Markers in Adults With CD19-Positive B-Cell Acute Lymphocytic Leukemia
Fludarabine, Cyclophosphamide, Levetiracetam - CD19 Positive, B-ALL
Phase 1Not yet recruitingMedical University of South Carolina182027-02-012026-11-13
Combining Neo-adjuvant ATR-inhibition With Nodal SBRT for Early-stage Resectable HPV+ OPSCCs
ATRN-119, Stereotactic Body Radiation Therapy (SBRT) - HPV Positive Oropharyngeal Squamous Cell Carcinoma, Squamous Cell Carcinoma
Phase 1 / Phase 2Not yet recruitingAbramson Cancer Center at Penn Medicine352027-01-312026-10-27
Managing Hepatitis B (Hep. B) and Human Papilloma Virus (HPV) Related Cancers and Mental Health.
Gardasil 9 vaccine, Hepatitis B Virus Vaccine(HBV), Cognitive Behavioral Therapy - Hepatitis B, Human Papilloma Virus
Phase 4Not yet recruitingEunice Dube21402027-01-302026-07-30
Combating Related Epidemics in HCV
Cepheid GeneXpert HCV Test, INSTI HIV - 1/2 Antibody, bioLytical Laboratories iStatis Hepatitis B Surface Antigen Test - HIV - Human Immunodeficiency Virus, Hepatitis B Virus (HBV)
Phase 4Not yet recruitingDuke University12802027-01-202026-11-09
Testing the Safety of Anti-Cancer Drug, CX-5461 (Pidnarulex), in Treating Lymphoma With Specific Changes in the MYC Gene
Biopsy Procedure, Biospecimen Collection, Computed Tomography - Burkitt Lymphoma, Double-Expressor Lymphoma
Phase 1 / Phase 2RecruitingNational Cancer Institute (NCI)502027-01-112026-10-14
Depletion of CD45RA Positive Naive T Cells for the Prevention of Graft Versus Host Disease in Older Patients Undergoing Allogeneic Hematopoietic Cell Transplantation for Acute Leukemia or Myelodysplastic Syndrome
Allogeneic CD34+-enriched and CD45RA-depleted PBSCs, Biospecimen Collection, Bone Marrow Aspiration - Acute Biphenotypic Leukemia, Acute Leukemia
Phase 2Not yet recruitingFred Hutchinson Cancer Center522027-01-012026-09-14
Study Of KITE-753 in R/R B-Cell ALL
KITE-753 - B-cell Acute Lymphoblastic Leukemia
Phase 1Not yet recruitingM.D. Anderson Cancer Center182026-12-312026-09-11
Zopapogene Imadenovec for the Treatment of Recurrent Respiratory Papillomatosis in Children
Zopapogene imadenovec-drba - Recurrent Respiratory Papillomatosis (RRP), Juvenile-onset Recurrent Respiratory Papillomatosis
Phase 3Not yet recruitingPrecigen, Inc152026-12-312026-10-28
Phase 1 Trial to Evaluate Safety and Immunogenicity of MVA-BN-EBV in Healthy Young Adults
MVA-BN-EBV, Placebo - Epstein Barr Virus (EBV) Infection
Phase 1Not yet recruitingBavarian Nordic152026-12-152026-10-22
B-Ensure: Long-term Follow-up Study to Evaluate Durability of Treatment Response in Previous Bepirovirsen Study Participants
Bepirovirsen - Hepatitis B
Phase 4Not yet recruitingGlaxoSmithKline3032026-12-032026-11-02
A Study of Sonrotoclax (BGB-11417) in Children With Relapsed or Refractory Acute Myeloid Leukemia and B-cell Acute Lymphoblastic Leukemia
sonrotoclax, Azacitidine, Inotuzumab ozogamicin - Relapsed Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia
Phase 1 / Phase 2Not yet recruitingBeOne Medicines302026-12-012026-10-26

Showing 20 of 5370. Sign in to see all of them.

Narrower conditions

Hepatitis B (1006)  ·  Burkitt Lymphoma (977)  ·  Hepatitis B, Chronic (866)  ·  Precursor Cell Lymphoblastic Leukemia-Lymphoma (591)  ·  Lymphoma, Large B-Cell, Diffuse (576)  ·  Papillomavirus Infections (568)  ·  Lymphoma, Follicular (525)  ·  Lymphoma, Non-Hodgkin (515)  ·  Lymphoma, Mantle-Cell (510)  ·  Leukemia, Lymphocytic, Chronic, B-Cell (471)  ·  Lymphoma (471)  ·  Lymphoma, B-Cell, Marginal Zone (458)  ·  Lymphoma, Large-Cell, Immunoblastic (445)  ·  Cytomegalovirus Infections (370)  ·  Hodgkin Disease (362)

Broader conditions

Virus Diseases (5282)  ·  Infections (5275)  ·  Communicable Diseases (2671)  ·  Pathological Conditions, Signs and Symptoms (2487)  ·  Herpesviridae Infections (2400)  ·  Pathologic Processes (2347)  ·  Disease Attributes (2193)  ·  Tumor Virus Infections (2036)  ·  Blood-Borne Infections (2027)  ·  Digestive System Diseases (1903)  ·  Liver Diseases (1752)  ·  Hepatitis, Viral, Human (1711)  ·  Hepadnaviridae Infections (1707)  ·  Neoplasms (1679)

Interventions

Cyclophosphamide (241)  ·  entecavir (198)  ·  Tenofovir (168)  ·  Rituximab (122)  ·  Etoposide (112)  ·  peginterferon alfa-2a (111)  ·  Vincristine (102)  ·  Filgrastim (98)  ·  Methotrexate (97)  ·  Peripheral Blood Stem Cell Transplantation (96)  ·  Cytarabine (94)  ·  fludarabine phosphate (91)  ·  Doxorubicin (83)  ·  Radiotherapy (80)  ·  Hepatitis B Vaccines (78)

Sponsors

GlaxoSmithKline (329)  ·  National Cancer Institute (NCI) (186)  ·  National Institute of Allergy and Infectious Diseases (NIAID) (182)  ·  Merck Sharp & Dohme LLC (129)  ·  Hoffmann-La Roche (71)  ·  Fred Hutchinson Cancer Center (66)  ·  Gilead Sciences (54)  ·  M.D. Anderson Cancer Center (44)  ·  Bristol-Myers Squibb (42)  ·  Sanofi Pasteur, a Sanofi Company (40)  ·  Third Affiliated Hospital, Sun Yat-Sen University (39)  ·  Memorial Sloan Kettering Cancer Center (38)  ·  National Taiwan University Hospital (38)  ·  University of Washington (38)  ·  Assistance Publique - Hôpitaux de Paris (35)

Countries

United States (2122)  ·  China (847)  ·  France (328)  ·  Canada (312)  ·  South Korea (267)  ·  Germany (241)  ·  United Kingdom (233)  ·  Italy (210)  ·  Taiwan (204)  ·  Australia (200)  ·  Spain (199)  ·  Belgium (156)  ·  Hong Kong (133)  ·  Thailand (122)  ·  New Zealand (120)

Top investigators

Liang Peng, Doctor (13)  ·  Robert Yarchoan, M.D. (11)  ·  Ajay Gopal (9)  ·  Anna Wald, MD, MPH (9)  ·  Ramya M Ramaswami, M.D. (8)  ·  Elias Jabbour (7)  ·  Helen E Heslop, MD (7)  ·  Marc G Ghany, M.D. (7)

Results publications

PMID 41276263, PMID 41671463, PMID 37781954, PMID 38700045, PMID 39807668, PMID 35622074, PMID 28427875, PMID 34515338, PMID 27422279, PMID 32499241, PMID 19052126, PMID 19935017, PMID 32184277, PMID 24915612, PMID 28404091, PMID 28404092, PMID 29405329, PMID 31824976, PMID 33460002, PMID 35599306, PMID 36263798, PMID 15470215, PMID 19187608, PMID 19236277, PMID 19236279, PMID 21182232, PMID 22225814, PMID 22436845, PMID 23046671, PMID 23234725, PMID 23518903, PMID 24731816, PMID 25424785, PMID 25424918, PMID 25788199, PMID 25987775, PMID 27658343, PMID 29074187, PMID 29211620, PMID 30982556, PMID 31042791, PMID 32589970, PMID 32710245, PMID 33857679, PMID 35149535, PMID 35941076, PMID 36066965, PMID 37166199, PMID 38551807, PMID 40237463

NIH funding

P30CA015704 (26), P30CA033572 (25), 2016 (21), 2017 (21), 2023 (20), P30CA043703 (19), 2018 (18), 2019 (18), U01CA121947 (18), 2014 (17), U10CA032102 (17), 2009 (15), P30CA006973 (14), 2015 (13), P30CA015083 (12)